Biocare Medical and PreciPoint Join Forces to Enhance Digital Pathology Solutions

Exciting Partnership in Digital Pathology

In a significant move for the field of digital pathology, Biocare Medical and PreciPoint GmbH have entered into a co-exclusive distribution partnership aimed at enhancing the accessibility and affordability of digital slide scanning solutions. This collaboration not only seeks to improve digital workflow efficiency but also to integrate advanced imaging technologies into the immunohistochemistry (IHC) and in situ hybridization (ISH) domains.

Since its inception, Biocare Medical has been a cornerstone in providing reliable reagents and platforms for IHC and ISH applications. With the ongoing demand for more proficient, cost-effective solutions to meet laboratory needs, this strategic partnership focuses on delivering digital slide scanning systems that align seamlessly with Biocare’s existing workflows.

Supporting Laboratories on Their Digital Journey

The agreement entails Biocare Medical acting as a co-exclusive distributor of PreciPoint's compact digital pathology imaging solutions. This includes not only slide scanners but also software designed specifically for clinical and research applications in IHC and ISH. The objective is to expand Biocare’s offerings to include digital-ready workflow solutions that enable laboratories to access high-quality imaging tools without incurring the substantial costs typical of high-throughput systems.

As digital pathology continues to gain traction, laboratories are increasingly seeking practical solutions that facilitate the adoption of digital processes without overwhelming complexity. PreciPoint's offerings provide an accessible entry point for labs venturing into digital pathology. The flexible scanning systems cater to both novice users looking to streamline their operations and experienced practitioners requiring adaptable solutions for various applications including assay development and quality assessment.